Trade Senseonics Holdings, Inc. - SENS CFD

Add to favourite

0.4122

2.87%

0.0067

Low: 0.3982

High: 0.425

Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.0067

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Senseonics Holdings Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	0.4007
Open*	0.4003
1-Year Change*	-31.58%
Day's Range*	0.3982 - 0.425
52 wk Range	0.46-1.27
Average Volume (10 days)	1.91M
Average Volume (3 months)	48.03M
Market Cap	274.65M
P/E Ratio	-100.00K
Shares Outstanding	528.28M
Revenue	19.93M
EPS	-0.06
Dividend (Yield %)	N/A
Beta	0.88
Next Earnings Date	Mar 13, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	0.4122	0.0084	2.08%	0.4038	0.4250	0.3982
Apr 17, 2024	0.4007	-0.0333	-7.67%	0.4340	0.4340	0.3974
Apr 16, 2024	0.4253	-0.0082	-1.89%	0.4335	0.4382	0.4253
Apr 15, 2024	0.4290	-0.0494	-10.33%	0.4784	0.4803	0.4282
Apr 12, 2024	0.4782	-0.0131	-2.67%	0.4913	0.4924	0.4712
Apr 11, 2024	0.4985	0.0003	0.06%	0.4982	0.5062	0.4805
Apr 10, 2024	0.4903	-0.0223	-4.35%	0.5126	0.5126	0.4882
Apr 9, 2024	0.5197	0.0215	4.32%	0.4982	0.5266	0.4982
Apr 8, 2024	0.5083	0.0220	4.52%	0.4863	0.5174	0.4791
Apr 5, 2024	0.4882	-0.0031	-0.63%	0.4913	0.5102	0.4822
Apr 4, 2024	0.4884	-0.0148	-2.94%	0.5032	0.5132	0.4782
Apr 3, 2024	0.5090	0.0008	0.16%	0.5082	0.5142	0.4963
Apr 2, 2024	0.5049	-0.0133	-2.57%	0.5182	0.5182	0.4982
Apr 1, 2024	0.5182	-0.0139	-2.61%	0.5321	0.5341	0.5182
Mar 28, 2024	0.5285	-0.0332	-5.91%	0.5617	0.5672	0.5282
Mar 27, 2024	0.5610	0.0030	0.54%	0.5580	0.5660	0.5482
Mar 26, 2024	0.5503	-0.0127	-2.26%	0.5630	0.5647	0.5482
Mar 25, 2024	0.5617	-0.0043	-0.76%	0.5660	0.5747	0.5580
Mar 22, 2024	0.5603	-0.0057	-1.01%	0.5660	0.5682	0.5460
Mar 21, 2024	0.5595	-0.0114	-2.00%	0.5709	0.5732	0.5554

Senseonics Holdings, Inc. Events

Time (UTC)	Country	Event
Tuesday, May 7, 2024
Time (UTC) 20:00	Country US	Event Q1 2024 Senseonics Holdings Inc Earnings Release Q1 2024 Senseonics Holdings Inc Earnings Release Forecast - Previous -
Thursday, May 16, 2024
Time (UTC) 14:00	Country US	Event Senseonics Holdings Inc Annual Shareholders Meeting Senseonics Holdings Inc Annual Shareholders Meeting Forecast - Previous -
Wednesday, May 22, 2024
Time (UTC) 14:00	Country US	Event Senseonics Holdings Inc Annual Shareholders Meeting Senseonics Holdings Inc Annual Shareholders Meeting Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	16.389	13.675	4.949	21.301	18.913
Revenue	16.389	13.675	4.949	21.301	18.913
Cost of Revenue, Total	13.663	14.486	22.315	40.749	27.059
Gross Profit	2.726	-0.811	-17.366	-19.448	-8.146
Total Operating Expense	85.255	72.174	107.53	152.361	106.491
Selling/General/Admin. Expenses, Total	31.634	29.154	41.351	72.784	47.569
Research & Development	39.719	27.217	20.413	38.43	31.863
Operating Income	-68.866	-58.499	-102.581	-131.06	-87.578
Interest Income (Expense), Net Non-Operating	211.087	-243.802	-59.57	16.022	-6.072
Other, Net	-0.102	-0.173	-13.017	-0.511	-0.321
Net Income Before Taxes	142.119	-302.474	-175.168	-115.549	-93.971
Net Income After Taxes	142.119	-302.474	-175.168	-115.549	-93.971
Net Income Before Extra. Items	142.119	-302.474	-175.168	-115.549	-93.971
Net Income	142.119	-302.474	-175.168	-115.549	-93.971
Income Available to Common Excl. Extra. Items	142.119	-302.474	-175.168	-115.549	-93.971
Income Available to Common Incl. Extra. Items	142.119	-302.474	-175.168	-115.549	-93.971
Diluted Net Income	142.119	-302.474	-175.168	-115.549	-93.971
Diluted Weighted Average Shares	618.206	422.321	227.912	188.754	157.429
Diluted EPS Excluding Extraordinary Items	0.22989	-0.71622	-0.76858	-0.61217	-0.59691
Diluted Normalized EPS	0.23028	-0.7131	-0.66568	-0.61006	-0.59691
Total Adjustments to Net Income					0
Unusual Expense (Income)	0.239	1.317	23.451	0.398

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total revenue	4.126	4.137	5.571	4.622	3.714
Revenue	4.126	4.137	5.571	4.622	3.714
Cost of Revenue, Total	3.709	3.723	4.952	3.866	2.89
Gross Profit	0.417	0.414	0.619	0.756	0.824
Total Operating Expense	23.994	23.846	24.533	23.175	19.934
Selling/General/Admin. Expenses, Total	7.455	7.718	7.849	7.34	8.561
Research & Development	12.83	12.405	11.631	10.985	9.299
Unusual Expense (Income)		0	0.101	0.984	-0.816
Operating Income	-19.868	-19.709	-18.962	-18.553	-16.22
Interest Income (Expense), Net Non-Operating	-0.71	21.01	30.513	-41.797	120.503
Other, Net	0.155	0.023	0.01	-0.041	-0.052
Net Income Before Taxes	-20.423	1.324	11.561	-60.391	104.231
Net Income After Taxes	-20.423	1.324	11.561	-60.391	104.231
Net Income Before Extra. Items	-20.423	1.324	11.561	-60.391	104.231
Net Income	-20.423	1.324	11.561	-60.391	104.231
Income Available to Common Excl. Extra. Items	-20.423	1.324	11.561	-60.391	104.231
Income Available to Common Incl. Extra. Items	-20.423	1.324	11.561	-60.391	104.231
Diluted Net Income	-20.423	1.324	11.561	-60.391	104.231
Diluted Weighted Average Shares	567.125	540.533	647.785	472.476	601.331
Diluted EPS Excluding Extraordinary Items	-0.03601	0.00245	0.01785	-0.12782	0.17333
Dividends per Share - Common Stock Primary Issue	0	0		0	0
Diluted Normalized EPS	-0.03601	0.00245	0.018	-0.12574	0.17198
Dilution Adjustment	0			0

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	161.2	144.413	30.246	127.758	158.106
Cash and Short Term Investments	144.015	129.906	18.005	95.938	136.793
Cash & Equivalents	34.658	29.197	18.005	95.938	136.793
Short Term Investments	108.222	96.445			0
Total Receivables, Net	2.787	2.416	2.986	10.486	7.097
Accounts Receivable - Trade, Net	2.451	1.973	2.986	10.379	7.097
Total Inventory	7.306	6.316	5.281	16.929	10.231
Prepaid Expenses	7.092	5.775	3.69	4.226	3.985
Total Assets	177.673	198.928	35.918	132.801	159.973
Property/Plant/Equipment, Total - Net	4.144	1.308	3.685	2.001	1.75
Other Long Term Assets, Total	0.076	1.325	0.101	3.042	0.117
Total Current Liabilities	31.471	18.394	16.638	126.708	28.886
Accounts Payable	0.419	1.204	1.762	4.285	4.407
Accrued Expenses	15.439	14.261	11.523	18.599	13.449
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	15.579	2.926	3.202	103.787	10
Other Current Liabilities, Total	0.034	0.003	0.151	0.037	1.03
Total Liabilities	142.593	384.463	177.19	141.45	88.712
Total Long Term Debt	56.383	59.798	57.216	11.8	40.886
Long Term Debt	56.383	59.798	57.216	11.8	40.886
Other Liabilities, Total	54.739	306.271	103.336	2.942	18.94
Total Equity	35.08	-185.535	-141.272	-8.649	71.261
Common Stock	0.48	0.447	0.266	0.203	0.177
Additional Paid-In Capital	806.488	765.215	504.162	464.491	428.878
Retained Earnings (Accumulated Deficit)	-808.866	-950.985	-648.511	-473.343	-357.794
Total Liabilities & Shareholders’ Equity	177.673	198.928	35.918	132.801	159.973
Total Common Shares Outstanding	479.637	447.282	265.583	203.453	176.918
Other Current Assets, Total		0	0.284	0.179
Property/Plant/Equipment, Total - Gross	6.182	2.838	4.787	2.755
Accumulated Depreciation, Total	-2.038	-1.53	-1.102	-0.754
Long Term Investments	12.253	51.882	1.886
Preferred Stock - Non Redeemable, Net	37.656		2.811
Cash	1.135	4.264
Other Equity, Total	-0.678	-0.212

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Current Assets	146.14	138.229	146.336	161.2	169.294
Cash and Short Term Investments	125.407	117.618	128.444	144.015	154.199
Cash				1.135
Cash & Equivalents	55.759	28.551	45.085	34.658	35.484
Total Receivables, Net	3.668	3.916	3.534	2.787	2.493
Accounts Receivable - Trade, Net	3.45	3.675	3.404	2.451	2.124
Total Inventory	9.726	9.194	8.195	7.306	7.257
Prepaid Expenses	7.339	7.501	6.163	7.092	5.345
Other Current Assets, Total
Total Assets	154.065	153.362	158.533	177.673	182.67
Property/Plant/Equipment, Total - Net	6.195	6.265	1.042	4.144	1.183
Other Long Term Assets, Total	1.73	1.415	2.998	0.076	3.342
Total Current Liabilities	17.302	15.861	14.277	31.471	57.648
Accounts Payable	2.669	0.975	0.646	0.419	0.684
Accrued Expenses	14.633	14.886	13.56	15.439	13.321
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	0	0	0	15.579	15.223
Other Current Liabilities, Total	0	0	0.071	0.034	28.42
Total Liabilities	64.344	63.169	56.413	142.593	197.735
Total Long Term Debt	40.485	39.108	37.479	56.383	53.434
Long Term Debt	40.485	39.108	37.479	56.383	53.434
Other Liabilities, Total	6.557	8.2	4.657	54.739	86.653
Total Equity	89.721	90.193	102.12	35.08	-15.065
Preferred Stock - Non Redeemable, Net	37.656	37.656	37.656	37.656
Common Stock	0.528	0.493	0.48	0.48	0.478
Additional Paid-In Capital	903.665	880.129	871.746	806.488	806.069
Retained Earnings (Accumulated Deficit)	-852.069	-827.965	-807.542	-808.866	-820.427
Total Liabilities & Shareholders’ Equity	154.065	153.362	158.533	177.673	182.67
Total Common Shares Outstanding	528.176	492.827	479.78	479.637	478.212
Short Term Investments	69.648	89.067	83.359	108.222	118.715
Long Term Investments	0	7.453	8.157	12.253	8.851
Other Equity, Total	-0.059	-0.12	-0.22	-0.678	-1.185

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	142.119	-302.474	-175.168	-115.549	-93.971
Cash From Operating Activities	-66.312	-56.078	-67.422	-136.047	-90.771
Cash From Operating Activities	0.985	1.239	1.141	1.001	0.27
Non-Cash Items	-206.945	246.661	92.82	-8.045	9.606
Cash Interest Paid	6.568	7.822	4.726	5.233	3.136
Changes in Working Capital	-2.471	-1.504	13.785	-13.454	-6.676
Cash From Investing Activities	26.882	-148.749	-0.181	-1.045	19.426
Capital Expenditures	-0.312	-0.21	-0.181	-1.045	-0.989
Other Investing Cash Flow Items, Total	27.194	-148.539		0	20.415
Cash From Financing Activities	41.762	220.083	-10.13	96.237	191.988
Financing Cash Flow Items	-2.57	195.072	-0.627	-8.343	-2.703
Issuance (Retirement) of Stock, Net	47.258	27.849	0.576	29.58	151.761
Issuance (Retirement) of Debt, Net	-2.926	-2.838	-10.079	75	42.93
Net Change in Cash	2.332	15.256	-77.733	-40.855	120.643

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	1.324	142.119	130.558	190.949	86.718
Cash From Operating Activities	-19.848	-66.312	-48.925	-34.341	-20.159
Cash From Operating Activities	0.236	0.985	0.751	0.52	0.263
Non-Cash Items	-20.163	-206.945	-177.963	-221.841	-101.792
Cash Interest Paid	1.756	6.568	5.137	3.381	1.762
Changes in Working Capital	-1.245	-2.471	-2.271	-3.969	-5.348
Cash From Investing Activities	29.947	26.882	19.532	42.108	19.666
Capital Expenditures	-0.057	-0.312	-0.255	-0.211	-0.137
Cash From Financing Activities	-0.807	41.762	31.416	4.197	6.043
Issuance (Retirement) of Stock, Net	14.893	47.258	35.526	8.306	8.237
Issuance (Retirement) of Debt, Net	-15.7	-2.926	-2.926	-2.926	-2.194
Net Change in Cash	9.292	2.332	2.023	11.964	5.55
Other Investing Cash Flow Items, Total	30.004	27.194	19.787	42.319	19.803
Financing Cash Flow Items		-2.57	-1.184	-1.183

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Senseonics Holdings, Inc. Company profile

Senseonics Holdings is a medical technology company that develops and manufactures continuous glucose monitoring (CGM) systems, specialising in long-term, implantable CGM systems for diabetes patients. It was founded in 1996 and trades on the New York Stock Exchange (NYSE) under the ticker SENS.

Headquartered in Maryland, US, the company had its initial public offering (IPO) in 2016, with an underwritten public offering of 15,800,000 shares of its common stock at $2.85 a share. Leerink Partners LLC and Canaccord Genuity acted as joint book-running managers for the offering, with Raymond James & Associates as lead manager and BTIG LLC as co-manager.

In February 2022, Senseonics’ Eversense E3 Continuous Glucose Monitoring System, touted as the first and only such CGM system, was approved for use for up to six months by the US Food and Drug Administration (FDA). The technology was reported to be available to patients in the US by the second quarter of 2022 through Senseonics’ global commercial partner, Ascensia Diabetes Care

The company’s partnership with Ascencia began in August 2020, when the pair announced a collaboration and commercialisation agreement that made Ascencia the sole distributor of Senseonics’ Eversense CGM systems worldwide. At that same time, Seseonics announced a financing agreement with Ascencia’s parent company, Masters Special Situations. The two agreements collectively made for $80m of debt and equity capital.

Industry:

Medical Equipment, Supplies & Distribution (NEC)

20451 Seneca Meadows Pkwy
GERMANTOWN
MARYLAND 20876-7005
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024